Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Eguchi

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 4, 2021
Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liverYasuyuki Tamai, Zhen Chen, Yue Wu, et al.
Antioxidants (Basel, Switzerland)|September 27, 2025
Clinical Evaluation of Oxidative Stress Markers in Patients with Long COVID During the Omicron Phase in JapanOsamu Mese, Yuki Otsuka, Yasue Sakurada, et al.
Scientific Reports|September 25, 2025
Conjugated bile acids in serum reflect disease severity and predict survival in chronic liver disease of humans and ratsAkiko Eguchi, Motoh Iwasa, Teruo Miyazaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 9, 2017
Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infectionRyosuke Sugimoto, Motoh Iwasa, Nagisa Hara, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 6, 2018
Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligationAkiko Eguchi, Yukinori Koyama, Alexander Wree, et al.
Biochemical and Biophysical Research Communications|October 3, 2002
Enhancement of phage-mediated gene transfer by nuclear localization signalTeruo Akuta, Akiko Eguchi, Hajime Okuyama, et al.
Nanomedicine (London, England)|May 29, 2015
Redox nanoparticles as a novel treatment approach for inflammation and fibrosis associated with nonalcoholic steatohepatitisAkiko Eguchi, Toru Yoshitomi, Milos Lazic, et al.
Microbiology and Immunology|January 22, 2004
Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTLKoutetsu Lee, Hiroshi Takenaka, Yukio Yoneda, et al.
Hepatology Communications|February 7, 2018
Neutrophil gelatinase-associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseasesKyoko Yoshikawa, Motoh Iwasa, Akiko Eguchi, et al.
Metabolic Brain Disease|June 30, 2016
Factors contributing to the development of overt encephalopathy in liver cirrhosis patientsMotoh Iwasa, Ryosuke Sugimoto, Rumi Mifuji-Moroka, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 4, 2021
Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liverYasuyuki Tamai, Zhen Chen, Yue Wu, et al.
Antioxidants (Basel, Switzerland)|September 27, 2025
Clinical Evaluation of Oxidative Stress Markers in Patients with Long COVID During the Omicron Phase in JapanOsamu Mese, Yuki Otsuka, Yasue Sakurada, et al.
Scientific Reports|September 25, 2025
Conjugated bile acids in serum reflect disease severity and predict survival in chronic liver disease of humans and ratsAkiko Eguchi, Motoh Iwasa, Teruo Miyazaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 9, 2017
Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infectionRyosuke Sugimoto, Motoh Iwasa, Nagisa Hara, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 6, 2018
Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligationAkiko Eguchi, Yukinori Koyama, Alexander Wree, et al.
Biochemical and Biophysical Research Communications|October 3, 2002
Enhancement of phage-mediated gene transfer by nuclear localization signalTeruo Akuta, Akiko Eguchi, Hajime Okuyama, et al.
Nanomedicine (London, England)|May 29, 2015
Redox nanoparticles as a novel treatment approach for inflammation and fibrosis associated with nonalcoholic steatohepatitisAkiko Eguchi, Toru Yoshitomi, Milos Lazic, et al.
Microbiology and Immunology|January 22, 2004
Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTLKoutetsu Lee, Hiroshi Takenaka, Yukio Yoneda, et al.
Hepatology Communications|February 7, 2018
Neutrophil gelatinase-associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseasesKyoko Yoshikawa, Motoh Iwasa, Akiko Eguchi, et al.
Metabolic Brain Disease|June 30, 2016
Factors contributing to the development of overt encephalopathy in liver cirrhosis patientsMotoh Iwasa, Ryosuke Sugimoto, Rumi Mifuji-Moroka, et al.
Pageof 11